JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online February 17, 2009, 10.2967/jnmt.108.055004
doi:10.2967/jnmt.108.055004
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnmt.108.055004v1
37/1/31    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reinking, M. F.
Right arrow Articles by Osman, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinking, M. F.
Right arrow Articles by Osman, M. M.
Journal of Nuclear Medicine Technology Volume 37, Number 1, 2009 31-37
© 2009 by Society of Nuclear Medicine

Prospective Evaluation of Physiologic Uptake Detected with True Whole-Body 18F-FDG PET/CT in Healthy Subjects

Mark F. Reinking1 and Medhat M. Osman2

1 Department of Physical Therapy and Athletic Training, Edward and Margaret Doisy College of Health Sciences, Saint Louis University, St. Louis, Missouri; and 2 Division of Nuclear Medicine, Department of Radiology, Saint Louis University, St. Louis, Missouri

Correspondence: For correspondence or reprints contact: Mark F. Reinking, Department of Physical Therapy and Athletic Training, Edward and Margaret Doisy College of Health Sciences, Saint Louis University, 3437 Caroline St., Saint Louis University, St. Louis, MO 63104. E-mail: reinking{at}slu.edu

PET is a molecular imaging modality used to assess metabolic activity. Little is known about the physiologic uptake of radiopharmaceuticals such as 18F-FDG in healthy subjects. This study was designed to identify and describe normal patterns of physiologic uptake of 18F-FDG in healthy adult subjects and to examine the influence of low-level muscle activity during the 18F-FDG uptake phase. Methods: Twenty healthy adults received an intravenous injection of 18F-FDG and were subsequently scanned with a combined PET/CT scanner. The CT scan was used to accurately identify the location of 18F-FDG uptake. Of the 20 subjects, 10 were randomly selected to perform a low-level muscle activity during the 1-h 18F-FDG uptake phase. The PET/CT images were fused, and the location and intensity of metabolic activity were described for all subjects. Results: Muscle activity during the 18F-FDG uptake phase affected the pattern of 18F-FDG distribution on PET scans. In addition, the tissue uptake of 18F-FDG, although variable, showed some consistency among tissue types. Conclusion: The data suggested that technologists should be aware of low-level muscle activity before and during uptake to avoid potential false-positive interpretations. The data also showed that there is some variability in the normal physiologic uptake of 18F-FDG across subjects. Finally, the results suggested that 18F-FDG uptake may be used for the evaluation of muscle activity.

Key Words: PET; 18F-FDG; skeletal muscle







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2009 by the Society of Nuclear Medicine Technologist Section.